Insider Trading activities of Rocket Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rocket Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rocket Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rocket Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is RCKT. The reporting company's CIK number is 1281895.
The total value of stock buying since 2005 is $26,734,874.
The total value of stock sales since 2005 is $14,014.
The total value of stock option exercises since 2005 is $42,799.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rocket Pharmaceuticals, Inc. (RCKT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-08 0 $0 637 $14,014 0 $0
2018-04 0 $0 0 $0 21,875 $0
2017-09 0 $0 0 $0 12,500 $0
2017-01 60,000 $105,000 0 $0 0 $0
2016-05 10,000 $90,290 0 $0 0 $0
2015-07 0 $0 0 $0 9,857 $42,799
2015-02 4,423,264 $26,539,584 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rocket Pharmaceuticals, Inc. insiders (RCKT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-08-01 Yalamanchi Naveen Sale 637 22.00 14,014
2018-04-02 Southwell David P (Director) Option Ex 21,875 .00 0
2017-09-14 Ritter Dale (Vice President, Finance) Option Ex 12,500 .00 0
2017-01-06 Southwell David P (President and CEO) Buy 60,000 1.75 105,000
2016-05-13 Carroll J Martin (Director) Buy 10,000 9.03 90,290
2015-07-14 Kantesaria Devang (10% Owner) Option Ex 9,857 4.34 42,799
2015-02-23 Pitango G.c. Capital Holdings Ltd. (10% Owner) Buy 212,375 6.00 1,274,250
2015-02-23 Kantesaria Devang (10% Owner) Buy 814,166 6.00 4,884,996
2015-02-23 Devon Park Associates, Llc (10% Owner) Buy 814,166 6.00 4,884,996
2015-02-23 Care Capital Offshore Investments Iii Lp (10% Owner) Buy 603,832 6.00 3,622,992
2015-02-23 Medimmune Ventures, Inc. (10% Owner) Buy 416,667 6.00 2,500,002
2015-02-23 Karabelas Argeris N (Director) Buy 603,832 6.00 3,622,992
2015-02-23 Leschly Mark (10% Owner) Buy 958,226 6.00 5,749,356

Insider trading activities including stock purchases, stock sales, and option exercises of RCKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rocket Pharmaceuticals, Inc. (symbol RCKT, CIK number 1281895) see the Securities and Exchange Commission (SEC) website.